Officers
Directors
10% Owners
Performance
Get Filings
Insider
Title
Company
Date
Price
Return
Shares
Value
Velan Capital Investment Management Lp
Non-Executive
Jasper Therapeutics, Inc. (JSPR)
2024-02-08
$12.95
47.9%
350,000
$4,532,500
Return
Profit / (loss)
Cost
Total
47.9%
$2,170,000
$4,532,500